NCT03866252View on ClinicalTrials.gov

LSD Therapy for Persons Suffering From Major Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

September 29, 2022

Study Completion Date

December 1, 2022

Conditions
Major Depressive Disorder
Interventions
DRUG

LSD

LSD administration per os

Trial Locations (1)

4002

Universitäre Psychiatrische Kliniken, Basel

All Listed Sponsors
collaborator

Department of Psychiatry Basel (UPK Basel; Prof. Dr. med. Stefan Borgwardt)

UNKNOWN

lead

University Hospital, Basel, Switzerland

OTHER

NCT03866252 - LSD Therapy for Persons Suffering From Major Depression | Biotech Hunter | Biotech Hunter